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ON CERTAIN PECULIARITIES OF HYPERTENSION 
IN ITSENKO—CUSHING’S DISEASE AND PRIMARY 
(TUMOROUS) HYPERCORTICISM
Е. K. Bozadjieva
High blood pressure is pointed out as one of the essential clinical signs 
of the condition in nearly all comprehensive studies on the Itsenko—Cushing 
syndrome (2,7,19). Nevertheless, systematic investigations in this direction 
cannot be found in the literature hitherto reviewed.
Plotz and assoc. (19) point out that hypertension in the Cushing syndrome 
exhibits high diastolic values and furthermore, that in cases of continuous 
hypertension enlargement of cardiac dimensions occurs. Vassiukova on 
her part states: „the cardio-vascular system in the symptomatic complex of 
the Itsenko—Cushing’s disease deserves a particular attention, as the changes 
occuring therein determine the severity of the morbid condition and its course, 
and are moreover the most frequent cause for the lethal outcome. In addition, 
of all cardiovascular symptoms observed, an outstanding role is played by 
hypertension, usually exhibiting a course characterized by high systolic and 
diastolic values“ .
We made it our aim to investigate the peculiarities in the nature and 
course of hypertension accompanying the Itsenko— Cushing’s disease and 
primary (tumorous) hypercorticism.
Material and Methods
The characteristic features of blood pressure were studied in 40 patients 
with diencephalic syndrome, running a course characteristic for the Itsenko— 
Cushing’s disease (slight form), 225 patients with severe form of the Itsenko— 
Cushing’s disease and 54 with primary (tumorous) hypercorticism, all of 
them undergoing treatment at the Therapeutical Dept. — all-Union Institute 
of Experimental Endocrinology in Moscow, over the period from 1947 — 1948 
to the middle of 1962 inclusive (Table 1). Twelve patients were also included, 
treated previously at the same Institute in whom the fundus oculi was in­
vestigated and the blood pressure accordingly measured. A major part of 
the patientes have been repeatedly treated at the Institute, some of them 
being followed up over a period of 8 and more years. The total number of 
patients amounts to 319. Of them 244 are females and 75 males, with a male 
to female ration 1 : 3.253, or women represented 76.5% of the total number, 
and men — 23.5%. The age of the patients ranged from 1 year and 6 months 
to 54 years. Thirty four patients were younger than 16 and 11 were beyond
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the 50-year age limit. The greater part of the patients — 210 (66%) were 
aged from 20—40 years (Table 2). Twenty two of a total of 54 patients with 
corticoadrenal tumours, i. e. 41% were beneath 21 years of age, and merely 
one was older than 50.
The entire series was distributed into three groups: without raised blood 
pressure, with benign hypertension and with malignant hypertension. Blood 
pressure was considered increased when the diastolic pressure reached or 
exceeded 90 millimetres of mercury. Alterations in the fundus oculi were 
assumed as a criterium for distinction of malignant from benign hyper­
tension, namely the presence of edema in the papilla or retina, hemorrhages 
and exudative changes in the retina, as it is universally accepted that edema 
of the papilla is the essential and one of the earliest diagnostical signs for 
the malignant phase of hypertension (8, 9, 12, 18, 23).
The results of the investigations were statistically elaborated (5). The 
systolic, diastolic and pulse pressure in individual groups of patients were 
comparatively evaluated with the mean values of blood pressure in the ge­
neral population, of the respective age and sex, as well as with the blood pres­
sure in groups of patients affected with ordinary benign hypertension, aged 
from 20—50 years and treated at the Naval Hospital — Varna during 1965.
The relationship between the type of hypertension and cardiac dimensions, 
severeness of proteinuria, osteoporosis manifestations and presence of diabdtes 
was also investigated.
The statistical elaboration utilizes the methods of поп-parametric, alter­
native and variation analysis. In the course of comparative evaluation of 
the height of blood pressure in our series with the normal levels for blood 
pressure in healthy persons (4), we aimed to find out: 1) what part of the pa­
tients were with blood pressure lower than normal for the respective age — 
sex group, established through P-50 (fiftieth percentile); 2) the number of 
patients with blood pressure between P-50 and P-75; 3) patients with blood 
pressure between P-75 and P-90 and 4) the number of patients with blood 
pressure exceeding P-90.
Theoreticalwise, the percentage ratio in the four groups listed should 
be 50 : 25 : 15 : 10. Every rather substantial deviation from the values 
indicated is a further corroboration of the fact that blood pressure in the 
patients investigated considerably differs from blood pressure in the healthy 
population.
We established, with the aid of alternative analysis, up to what extent 
was the difference between the percentages characterizing the various pa­
tients’ groups characteristic. For the purpose the ,,t“ criterium was utilized 
and the probability related to its degree.
The methods of variation analysis were employed with a view to establi­
shing the mean level of blood pressure in different cathegories of patients. 
The comparison was carried out with the aid of the ,,t“ criterium. In a rather 
restricted number of patients the degrees were in addition freely computed.
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Results
The distribution of the patients according to sex, type of hypertension 
and form of hypercorticism is illustrated in table 1. It is evident from the 
latter that 32 patients are free from hypertension (21 women and II men), 
149— with benign hypertension (119 females and 30malles)and 138 — with
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Women Men w M w M W M w M
Diencephalic
syndrome 7 3 12 5 12 i 31 9 40 9.72 2.76 12.54
Itsenko— 
Cushing’s 
Disease 7 7 81 20 78 32 166 59 225 52.03 18.5 70.53
Tumorous
Hyperadreno
corticism 7 1 26 5 14 1 47 7 54 14.7 2.2 16.93
Total
21 11 119 30 104 34 244 75 319 76.49 23.51 100
32 149 138 319 319
% 10 46.7 43.3 100
malignant hypertension (104 females and 34 males), or the same figures 
expressed in percentages, they are accordingly: without hypertension — 
10% of the patients, with benign hypertension — 46.7% and with malignant 
hypertension 43.3%.
On comparing the percentage of the patients with benign and malignant 
hypertension, it was found that ,,t“ is equal to 0.6, P <  0.5, which indicates 
that there is no essential difference in the distribution between benign and 
malignant hypertension in hypercorticism.
Out of a total of 75 men, 34 (or 45.3%) are affected with malignant hy­
pertension, whereas out of a total of 244 women, 104 are with malignant 
hypertension (42.62%). The difference in the percentages (t =  0.4, P <  0.5) 
is not significant, or in other words men and women as well, affected by 
hypercorticism, are also equally affected by malignant hypertension (Table 2).
The data derived from the comparison of the type of hypertension in 
the various forms of hypercorticism and the duration of the disease are sum-
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Distribution of the Patients According to Age, Sex and Form of Hyperadrenocorticism
Years 0-10 11—20 21—30 31—40 41-50 51-60 Total
Without women 2 1 4 7
Diencepha- hypertension men — 3 — — — — 3
lie syndrome
Benign women 1 2 7 2 12
hypertension men — 1 I 1 1 1 5
Malignant women 1 3 6 2 12
hypertension men — — 1 - — — 1
Without women 1 3 2 1 7
Itsenko—
hypertension men 1 2 3 1 — — 7
Benign women 5 32 34 8 2 81Cushing’ssyndro me hypertension mon 2 7 4 7 — — 20
Malignant women 3 6 24 27 12 6 78
hypertension men 1 7 9 12 2 1 32
Without women 1 2 1 3 7
Tumorous
hypertension men — — 1 — — — i
Hyper­
corticism
Benign women 7 4 5 7 2 1 26
hypertension men 1 — I 3 — — 5
Malignant women 3 3 3 2 3 14
hypertension men 1 — — — — — 1
Total 20 45 94 116 33 11 319
marised in table 3. The analysis of the latter reveals that the duration of 
benign and malignant hypertension in women with diencephalic syndrome 
is greater as compared to the duration in cases with a course free of hyper­
tonia; it is furthermore established that malignant and benign hypertensions 
do not differ significantly in this respect.
An essential difference insofar duration of the disease is concerned is pot 
marked among the group of women affected with the Itsenko—Cushing’s 
disease neither in benign and malignant hypertensions, nor in instances with 
a course not revealing increased blood pressure. In male patients with Itsenko- 
Cushing’s disease, the malignant hypertension exhibits a rather protracted 
course as compared to benign cases. Benign hypertension in females also 
appears to be with a rather longer duration as compared to males affected 
with the Itsenko — Cushing’s disease.
In tumorous hypercorticism, malignant hypertension in women is sub­
stantially more prolonged than benign.
It is our impression also, that in women with diencephalic syndrome wit­
hout blood pressure rise the disease exhibits a longer duration as compared
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Dependence of Hypertension In Hypeadrenocorticism upon the Duration of the Disease
I t s e n k o —C u s h i n g ’s 
d i s e a s e
T u m o r o u s  h y p e r a d -  
r e n o c o r t i c i s m
D i e n c e p h a l i c
s y n d r o m e
to to to
n -H t P n 41 t P n 41 1 P
s S S
without hypert. 7 5 ± 3 0 . 8 7 < 0 , 5 7 3 4 2 1,2 « « 0 , 2 7 5 4 3 2 ,1 1 « « 0 , 0 5
benign hypert. 81 6 ± 4 2 6 2 ± 2 12 9 4 5
Q
p without hypert. 7 5 4 3 1 ,6 4 « « 0 , 1 7 3 4 2 1 ,6 4 < 0 , 2 7 5 4 3 2 « « 0 , 0 5
o mal. hypertens. 7 8 7 ± 4 14 5 ± 4 12 9 4 5
benign hypert. 81 6 ± 4 1 ,5 2 « « 0 , 1 2 6 2 ± 2 2 , 8 3 < 0 , 0 1 12 9 4 5
mal. hypertens 7 8 7 4 4 14 5 ± 4 12 9 4 5
without hypertension 7 6 ± 4 0 . 6 « « 0 , 5
2 0 4 4 3
C
<u without hypertension 7 6 ± 4
y  mal. hypertens. 3 2 6 ± 4
ben. hypertension 2 0 4 4 3 2 , 0 < 0 , 0 5
mal. hypertension 3 2 6 4 4
without women 7 0 , 4 > 0 , 5
hypertension men 7 6 ± 4
women
benign hypertension 81 6 ± 4 2 , 3 « « 0 , 0 2 2 6 2 4 2 0 , 8 < 0 , 5
men 2 0 4 ± 3 5 3 ± 3
malignant women 7 8 7 ± 4 1,2 « « 0 , 2
hypertension men 3 2 6 ± 4
w i t h o u t m i l i g n a n i
h y p e r t e n s i o n b e n i g n  h y p e r t e n s i o n h y p e r t e n s i o n
to to to
n 41 t P n 41 t P n 41 t P£ S S
diencephalic s; 7 5 ± 3 12 9 ± 5 2 , 0 < 0 , 0 5 12 9 4 5 1,21 % 0 , 2
Its —Cush. dis. 7 5 ± 3 81 6 ± 4 7 8 7 4 4
Q)
|  diencephalic s. 7 5 ± 3 2 , 1 4 « « 0 , 0 5 12 9 ± 5 4 , 6 < 0 , 0 0 1 12 9 4 5 2 , 1 6 < 0 , 0 5
^  tum.hyperadrenocorticism 7 3 ± 2 2 6 2 ± 2 14 5 4 4
Its.—Cush, disease 7 5 ± 3 2 , 1 4 « « 0 , 0 5 81 6 ± 4 6 , 0 < 0 , 0 0 1 7 8 7 4 4 1,9 « « 0 , 5
tum.hyperadrenocorticjsm 7 3 ± 2 2 6 2 ± 2 14 5 4 4
dienceph. syndr. 5 7 ± 6 1 , 0 < 0 , 5
Its.—Cush, syndr. 2 0 4 ± 3
w diencephalic syndrome 5 7 ± 6 1 ,2 4 < 0 , 5
^  tum.hyperadrenocorticism 5 3 ± 3
Its.—Cush, syndr. 2 0 3 ± 3 0 , 7 « « 0 , 5tum.hyperadrenocorticism 5 3 ± 3
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to tumorous hypercorticism without elevation of blood pressure. Tumorous 
hypercorticism without increased blood pressure in women is with shorter 
duration as compared to the duration of the disease in the same group of 
the Itsenko— Cushing’s syndrome. The benign hypertension in women with 
diencephalic syndrome is likewise characterized by a longer course as com­
pared to benign hypertension in women affected with the Itsenko—Cushing’s 
disease. In general, benign hypertension in the diencephalic syndrome in 
women is distinguished by a protracted course of the condition as compared 
to the duration in female patients with benign hypertension, due to the It­
senko—Cushing’s disease and tumorous hypercorticism. Anyway, a difference 
in the continuity of the disease among women affected with diencephalic 
syndrome with benign hypertension, and those affected by the Itsenko— 
Cushings’ disease and tumorous hypercorticism with malignant hypertension 
is not established. Rather more protracted is the duration of the condition 
in women affected by Itsenko—Cushing’s disease with benign hyperten 
sion as compared to women affected by tumorous hypercorticism. Malignant 
hypertension in females with diencephalic syndrome is likewise distingui­
shed by a prolonged duration of the affection as compared to women with 
tumorous hypercorticism. The same holds true for malignant hypertension 
in women with tumorous hypercorticism contrasted to females affected by 
the Itsenko—Cushing’s disease, in whom the duration of the morbid process 
is longer.
The percentile method was utilised in the course of elaborating the normal 
limits (level) of blood pressure. Thus, 50% of the cases exhibit blood pressure 
beneath the mean value (P 50) and 50% show blood pressure values above 
P 50. Moreover, 25% of the total number of cases should be placed between 
the P50 and P75 percentiles, 15% of all cases — between P75 and P90 and 
10% — beyond P90. The ratios just listed are observed among the population 
with normal blood pressure.
In order to find an answer to the question up to what extent the height 
of blood pressure among our patients differed from that in the healthy po­
pulation, we proceeded as follows:
1. According to age and sex, the percentiles were established within 
which the blood pressure of the patients investigated was located.
2. The results obtained for each individual group of patients were sum­
marized and illustrated in tables.
3. Computation was carried out of the percentage demonstrating the 
number of patients falling into the interval groups, enclosed within the res­
pective percentiles.
The analysis of the tables compiled by the authors of the paper, shows 
that the blood pressure of the patients studied, both systolic and diastolic, 
is considerably higher than the blood pressure in the healthy population. As 
regards the pluse pressure a similar rule was not established.
The comparison of blood pressure (systolic, diastolic and pulse) in pa­
tients with various forms of hyperadrenocorticism writh the mean blood 
pressure values for the respective age in the healthy population (4) showed 
that:
1. There is no essential difference in the systolic, diastolic and pulse 
pressures in women with Itsenko—Cushing’s disease and normal blood pres­
sure.
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2. In male patients of the same group the diastolic pressure, although 
within normal limits, is higher than that of the normal population (Table 4).
3. No deviations whatever from the diastolic, systolic and pulse pres­
sures of the population of the same age group are established in women with 
tumorous hyperadrenocorticism without hypertension (Table 4).
4. On the contrary, systolic pressure exhibits higher values than average 
for the normal population in patients with diencephalic syndrome (slight 
form of the Itsenko—Cushing’s disease). Diastolic pressure in men is likewise 
higher, whereas in women the pulse pressure displays a minor amplitude 
(Table 4).
5. A substantial difference exists in the sense of higher values for sy­
stolic, diastolic and pulse pressure, than that in the normal population in 
women with Itsenko-Cushing disease associated to hypertension, both benign 
and malignant (Table 4).
6. A similar picture is seen in men merely for malignant hypertension 
and systolic and diastolic pressures in benign hypertension. The pulse pres­
sure in the latter condition is insignificantly altered as compared to healthy 
population (Table 4).
It is worth mentioning that in diencephalic syndrome cases, in women 
and men alike, a substantial difference is noted in systolic and diastolic 
pressures both in benign and malignant hypertension, whereas for the pulse 
pressure such a difference is non existant (Table 4).
No substantial difference is established in systolic pressure on comparing 
the blood pressure in benign and malignant hypertension among females 
affected by Itsenko — Cushing’s disease, whereas it is present insofar diastolic 
and pulse pressures are concerned. A significant difference is found in the 
systolic pressure also in males affected by the Itsenko—Cushing disease.
A substantial difference is established insofar systolic, diastolic and pulse 
pressures are concerned during comparative investigations of men and women 
with malignant hypertension, or in other words, the values of the pres­
sures listed in malignant hypertension are substantially higher in men as 
compared to women (Table 5).
No significant difference is noted between the values of systolic and dia­
stolic pressures in benign hypertension in men and women, affected by It­
senko — Cushing’s disease. A difference is merely established in pulse pres­
sure, which is lower in males, i. e. with a minor amplitude than in females.
Also, it is interesting to know that no significant difference is observed 
between the systolic, diastolic and pulse pressures in malignant and benign 
hypertension in the group of patients with diencephalic syndrome.
During the parallel investigation of blood pressure values in benign and 
malignant hypertension in men and women with hypercorticism and those 
in patients with common hypertonic disease (Table 6), the following facts 
attracted attention in particular:
1. In diencephalic syndrome cases there is no significant difference bet- 
xveen benign hypertension in men and ordinary hypertonic disease.
2. There is no significant difference between the values of blood pressure 
in malignant hypertension in females with diencephalic syndrome and ordi­
nary hypertonic disease, except for the pulse pressure, found to be substanti­
ally lower in patients with diencephalic syndrome.
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Relationship between Benign and Malignant Hypertension in the Itsenko—Cushing's
Disease









































































































54± 16.58 2.66 <0.01
3. Considerable difference in the sense of lower values, is observed in 
benign hypertension among females with diencephalic syndrome.
4. In women affected by Itsenko-Cushing’s disease there is no difference 
between the diastolic pressure in benign and malignant hypertension and 
that in hypertonic disease. Systolic and pulse pressures in benign as well 
as in malignant hypertension are significantly lower.
5. Systolic and pulse pressures are substantially lower in men with 
benign hypertension, affected by Itsenko-Cushing disease, whereas diastolic 
pressure is analogous to that in hypertonic disease.
6. Systolic pressure in men with malignant hypertension, affected by 
Itsenko—Cushing disease does not differ from that in patients with hypertonic 
disease, whereas diastolic pressure is considerably higher, and pulse pressure— 
considerably low'er.
In all instance of tumorous hyperadrenocorticism, the pulse pressure is 
substantialy lower than that in hypertonic disease. In benign hypertension 
cases, the systolic pressure is likewise lcnver among females, whereas in malig­
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without women 7 — 7
hypertension men 3 — — 3
Diencephalic benign w omen 9 3 — 12
syndromes hypertension men — 4 — 4
malignant women 3 5 1 9
hypertension men — 1 — 1
without women 4 3 — 7
hypertension men 5 2 — 7
ltsenko benign women 43 34 2 79
Cushing’s hypertension men 8 9 1 18
disease malignant wo me n 15 53 10 78
hypertension men 8 17 7 32
without women — 6 — 6
hypertension me — 1 — 1
Tumorous benign women 4 18 — 22
hyperadre- hypertension men 2 3 — 5
nocorticism malignant women 2 11 — 13
hypertension men ------ - 1 — 1
Total 113 I 171 1 21 305(women 153 (women 133] (women 13) (women 234)
(men 26) | (men) 1 (men 8) (men 71)
The distribution of proteinuria in accordance with the type of hyper­
tension and form of hyperadrenocorticism is illustrated in table 7. In our 
series, in 61% of the patients without blood pressure increase, in 47% of 
those with benign hypertension and in 21% of the cases with malignant 
hypertension, proteinuria was not disclosed. The difference between the 
three groups of patients was substantial (between the first and second P <  
0.01, between second and third as well as between first and third P <  0.001). 
Heavy proteinuria was observed in 13.43% of the patients with malignant 
hypertension and merely in 2.14% of those with benign hypertension (P<0.05)
The dependence of cardiac dimension alterations upon the type of hyper­
tension and form of hyperadrenocorticism is demonstrated in table 8. In 16% 
of the patients of our series without blood pressure rise, in 7% of the total 
number with benign hypertension and merely in 1.6% of those with malig­
nant hypertension, hypertrophy of the heart was not encountered. The dif­
ference between the patients of first and third groups is rather significant 
(PcO.OOl).
The distribution of osteoporosis in compliance with the nature of hyper­
tension and form of hyperadrenocorticism is demonstrated in table 9. It 
illustrates that severe osteoporosis is more frequently met in malignant 
hypertension (78% against 22% in benign cases, P <  0.001).
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Distribution of Alterations in the Cardiac Size According to Sex Type of Hypertension
and Form of Hyperadrenocorticism
N o r m a l E n l a r g e d T o t a l  n u m b e r
h e a r t  s ize h e a r t  s i z e of  p a t i e n t s  
I n v e s t i g a t e d
without women i в 7
hypertension men — 3 3
Diencephalic benign women — 11 11
syndrome hypertension men 4 4
malignant women — 12 12
hypertension men — I 1
without women — 7 7
hypertension men — 6 6
Itsenko-Cushing’s benign women — 79 79
disease hypertension men i 17 18
malignant women — 71 71
hypertension men i 2 9 30













malignant women 1 12 13
hypertension men — — —
17 280 2 9 7
Diabetes was observed in 20% of our series. The dependence of the latter 
condition upon the character of hypertension is not proved (P<0.5).
We have the impression furthermore, that severe osteoporosis and dia­
betes as well are rarely encountered in instances of diencephalic syndrome.
Discussion and Inferences
Although authors like Pickering emphasize the importance of systematic 
investigations of hypertension in hyperadrenocorticism cases insofar eluci­
dation of the pathogenesis of hypertonic disease is concerned, relevant re­
ports in the literature are not found.
According to Mills (14), increased blood pressure is established in 85% 
of all patients with Cushind’s syndrome. Raker and assoc. (20) found arterial 
hypertony with diastolic pressure exceeding 100 millimeters of mercury in 
51 (81%) out of a series comprising 63 patients. Plotz and assoc. (19) establi­
shed hypertension in 84% among a group of 33 patients, and in 85% of a 
total of 189 cases described in literature sources. In our series of patients, 
increased blood pressure is encountered in 90%. The higher incidenceof 
hypertension established by the authors of the paper is very likely due to
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without women 4 i l ___ ___ 3
hypertension men 1 — 2 — —
Diencephalic benign women 3 5 2 — — 10
syndrome hypertension men 3 — — — 3
malignant women 1 4 5 ___ ___ 10
hypertension men — — — 1 — 1
without women 3 2 1 i 7
hypertension men — 1 4 1 — 6
Itsenko-Cushing’s benign women 4 18 43 4 5 2 4
disease hypertension men 1 1 10 — 6 18
malignant women 1 5 2 9 2 2 15 7 2
hypertension men — — 14 3 10 2 7

















malignant women 3 — 3 3 2 II
hypertension men — — — — — —
Total 3 2 3 9 126 37 41 2 7 5
the rather prolonged and systematic observations and follow up of patients, 
carried out at the Endocrinological Institute at Moscow, enabling the detect­
ion also of transitory or hypertensive conditions in the course of the di­
sease, characterized by a later occurrence.
It should be stressed in advance that our observations on the distribution 
of the patients by sex, namely, that female to male ratio amounts to 3.25 : 1, 
conform with those of Plotz and assoc. (19) (1 : 3), and differ from those 
reported by Forsham (7) who claims a 1 : 4 ratio. Our experience and that 
reported by Plotz are nearer the actual proportion, being the groups of 
patients studied by far more numerous.
Our observations upon the distribution of patients according to age con­
form in general oultine with those claimed by Forsham (7), who reached the 
conclusion that a greater number of the patients are in the third and fourth 
decade of life. And yet, the predilection of a still younger age in tumorous 
hyperadrenocorticism conditions should not be overlooked.
Of particular interest is the high incidence of malignant hypertension, 
noted in our series.
MacMahon, Close and Hass (quoted by 17) first in 1937 described the 
Cushing’s syndrome in two cases, with the characteristic for malignant hy­
pertension vascular changes, found post mortem. Subsequently, malignant 
hypertension in patients with Itsenko-Cushing’s syndrome was reported by
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other authors too. Kincaid-Smith and assoc. (12) in their seires of 197 pa­
tients with malignant hypertension recorded only one case with Itsenko- 
Cushing’s syndrome. Montgomery and Wei bourn (15) established “malignant 
changes in the fundus oculi” in four out of a total of 15 patients with Itsenko- 
Cushind’s syndrome.
According to the majority of writers (1, 12) malignant hypertension consti­
tutes a phase in the development of various hypertensive diseases, with an 
incidence not exceeding 1 per cent of the total number of cases with hyper­
tension. According to Perera (quoted by 12) this figure is 7 per cent. In com­
pliance with data issued by the Therapeutical Institute in Moscow, develop­
ment of malignant hypertension is observed in 1.5% of the total number 
of patients with hypertonic disease (3). Our investigations show that the 
incidence of malignant hypertension in hyperadrenocorticism amounts to 
43.3% and moreover, that between the latter and the incidence of benign 
hypertension in the same condition no difference exists. It should be further­
more pointed out that the age distribution of patients affected by hyper­
adrenocorticism strongly resembles the age distribution of malignant hy­
pertension (3, 9).
Contrary to malignant hypertension observed in common hypertensive 
conditions, affecting males more frequently (13, 9, 12, 16), our data prove 
that malignant hypertension in hyperadrenocorticism affect females and ma­
les with approximately equal incidence.
Welbourn (24) carried out comparative evaluation between the blood 
pressure in hyperadrenocorticism and the mean value of blood pressure among 
the healthy population, and found out that in all his patients, with the ex­
ception of systolic pressure in one woman and diastolic in two other, the 
blood pressure was higher than in healthy population. He could not reach 
more definitive conclusions on account of the relatively small number of 
patients personally studied (32).
The comparison of blood pressure with a) blood pressure in healthy indi­
viduals and b) in hypertonic disease reveals on the whole lower values of 
hypertension in hyperadrenocorticism, the latter tendency being particu­
larly pronounced in the pulse pressure; the latter in all forms of hyperadreno­
corticism is considerably lower than that in hypertonic disease, and in some 
instances (absence of arterial pressure rise, benign hypertension in males 
with Itsenko-Cushing’s disease and in all cases of diencephalic syndrome) 
it is identical to that encountered among the healthy population. It should 
be emphasized that pulse pressure in females with hyperadrenocorticism is 
usually higher as compared to males (Table 5) — a difference not marked in 
ordinary hypertension (t =  1.71, P <  0.1).
For the time being the finding of an explanation of these facts appears to 
be rather difficult. Miasnikov (3) points out that the relationship-maximum 
and minimum blood pressure values-is influenced far and foremost by the 
elasticity of the major blood vessels’ walls and by the contractile capacity 
of the heart. A reduced arterial elasticity accounts for simultaneous intensi­
fication of the increase of systolic and decrease of diastolic pressure. Mostly 
pronounced, this phenomenon is observed in atherosclerosis of the major 
arteries. It is known that changes in elasticity of the vascular walls bring 
about a rise in pulse pressure in hypertonia, whereas a weak cardiac muscle 
conditions the fall of pressure.
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It is emphasized by the majority of authors (2, 7, 19, 13) that arterio­
sclerosis is an early and often met complication of hyperadrenocorticism. On 
autopsy material, studied by Plotz and assoc. (19), arteriosclerosis (ranging 
from tiny lesions of the aorta to severe generalized arteriosclerosis) was 
established in 50 of a total of 56 investigated intentionally hyperadrenocorti­
cism cases. Maunix and Glenn (13) point out that in their series of 49 patients 
with Itsenko-Cushind’s syndrome, hypertension was frequently associated 
to arteriosclerosis, regardless of the young age, occasionally revealing a 
generalized characteristic feature. Biopsy studies show that changes in the 
minor vessels of the kidneys were more pronounced than anticipated. A com­
mon roentgenological finding in our series is the elongated and sclerosing 
aortal arch. Anyway, contrary to expectations, the pulse pressure in most 
of the cases did not exceed that of the healthy population. It is believed that 
in the latter case the myocardium is more heavily involved, and its condition 
mostly determines the systolic-diastolic amplitude, all the more that 
according to Plotz (19), the fatal outcome in 27% of the patients is caused 
by heart failure. The lack of evidence for hypercholesteremia in most cases 
is a further prove for some peculiarities in the course of arteriosclerosis in 
hyperadrenocorticism (19). In accordance with the opinion expressed by 
Pickering (18), the participation of nerve factors is excluded from the me­
chanisms of increased blood pressure in the Itsenko-Cushing syndrome.
Also it is interesting to note the fact that in malignant hypertension, in 
males and females alike, where a weaker cardiac muscle is reasonably anti­
cipated, the pulse pressure is highest.
In general, as already pointed out, the blood pressure in hyperadrenocorti­
cism displays lower values than in hypertonic disease except for diastolic 
pressure in malignant hypertension in women and men alike, affected by 
Itsenko-Cushing’s disease and tumorous hyperadrenocorticism.
The analysis of the data resulting from the comparative study of blood 
pressure in the different forms of hyperadrenocorticism, demonstrates that 
in malignant hypertension in females, the systolic pressure is not too high, 
contrary to diastolic pressure, which is significantly higher than that in be­
nign hypertension. Malignant hypertension in males is distinguished by 
higher values and severer course. In diencephalic syndrome cases there is no 
difference in the values of blood pressure between malignant and benign 
hypertension; the difference between them is determined mainly on the basis 
of changes occurring in the fundus of the eye. It should be further emphasi­
zed that malignant hypertension, regardless of the generally heavy and pro­
gressive course of the Itsenko-Cushing’s disease and tumorous hyperadreno­
corticism, displays a milder and rather more favourable evolution as com­
pared to malignant hypertension in other hypertensive conditions and the 
average lifespan is prolonged. It is known, that prior to the introduction of 
modern hypotensive means, the average life duration in malignant hyper­
tension cases did not exceed one, maximum two years. It is rather difficult 
to establish with precision the average duration of life in malignant hyper­
tension with our series of patients, but it is definitely much longer than 
two years. It is worth mentioning also that in the patients with Itsenko- 
Cushing’s disease -f malignant hypertension, studied more closely and in 
detail, a fluctuating course of the process is noticed, more particularly of 
the changes involving the fundus of the eye and blood pressure, with periods
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of exacerbation alternating, especially after treatment, periods of remissions. 
The fluctuation described in the course of malignant hypertension accompa­
nying the Itsenko-Cushing’s disease is very similar to the course of rheumatism.
Our investigations demonstrate that the vascular process in hyperadre- 
nocorticism, and especially in Itsenko-Cushing’s disease, bears a generalized 
characteristics. An accurate confrontation of the renal function to the type 
and severity of hypertension was not possible with our patients. Neverthe­
less, as far as renal function could be judged by proteinuria, we were impressed 
that it was more heavily damaged in comparatively few patients. On the 
whole, the observations and investigations carried out in our patients with 
malignant hypertension, conform with the statements of Keith, Wagner 
and Kernoham (9), insofar in malignant hypertension the „characteristic“ 
for the disease retinitis is associated to pronounced hypertension and ade­
quate renal function. In nearly all cases of our series the heart was enlarged. 
The only exception are several patients with tumorous hyperadrenocorticism. 
It is interesting to note that increased cardiac dimensions were disclosed 
even in cases without elevated blood pressure. It is well known that hyper­
trophy of the heart in hypertension is a sign of a lasting and persisting rise 
of blood pressure. The enlarged cardiac dimension in the latter case should 
be ascribed either to undetected, long since present hypertension, or to pri­
mary weakness of myocardium (myocardia insufficiency).
The severeness and widespreading of osteoporosis in our patients is clo­
sely related to the type and severity of hypertension. Also it is interesting 
to note that in individual cases exhibiting wavy course of malignant hyper­
tension, a parallel fluctuation is also observed in theseverity of the osteopo­
rotic process.
Casual relationship between the disturbances in the carbohydrate meta­
bolism and the type of hypertension was not established in our patients. 
According to Plotz and assoc. (19) obvious diabetes is found in 15% of the 
patients with hyperadrenocorticism, whereas according to Forsham (7), 
this figure reaches 20%. We too established evident diabetes in 20% of the 
cases.
According to Racker and assoc. (20), the severity of hypertension in hyper­
adrenocorticism depends on the duration of morbidity. They add however, 
that exceptions from this rule are existant.
The analysis of the results of our investigations shows that such a de­
pendence exists merely for malignant hypertension in males affected by 
Itsenko-Cushing’s disease and tumorous hyperadrenorcoticism as well. 
It is worth mentioning that malignant hypertension in diencephalic syndrome 
cases is distinguished with the longest duration of the morbid condition; 
the latter represents a light form of the Itsenko-Cushind’s syndrome, next 
coming the duration in Itsenko-Cushing’s disease and tumorous hyperadre­
nocorticism, or in other words, the malignant hypertension in slight forms 
of hyperadrenocorticism is characterized by a prolonged course of morbi­
dity. Thus it seems justified to assume that in the latter case a role is played 
not merely by the duration of the noxious action, but by its severity as well.
The pathogenesis of hypertension and malignant hypertension in parti­
cular in hyperadrenocorticism is as yet unclarified. Studies carried out by 
many writers (8, 14, 15, 18, 20, 24) show that surgical treatment of the 
Itsenko-Cushing’s disease and tumorous hyperadrenocorticism restores blood
17 On Certain Peculiaritis oi Hypertension in Itsenko-Cushing’s. . . 103
pressure within normal limits but, merely in cases in which surgery is in 
a position to exert a general effect on the morbid condition. In long lasting 
morbidity with deteriorization of the process and heavy involvement of 
the vessels and kidney, the blood pressure does not get normalized.
The exact mechanism of the blood pressure increase in hyperadrenocor- 
ticism, as already underscored, is unknown. Hypertension has been experi­
mentally induced with the aid of various cortico-adrenal hormones, cortisol 
and cortisone included (11), with duely proved definitive role in the patho­
genesis of the Itsenko-Cushing syndorme. There is also clinical experience on 
the development of malignant hypertension in the course of cortisone therapy 
(6, 22). In the Conu syndrome, usually brough about by hyperaldosteronism, 
increased blood pressure is likewise observed. Apparently, a variety of corti- 
coadrenal hormones or combinations, among which also cortisol, are important 
insofar etiology is concerned for the development and for the characteristic 
features of hypertension in hyperadrenocorticism. The good results after 
timely carried out surgical management are an important argument in favour 
of this concept.
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0 НЕКОТОРНХ ОСОБЕНОСТЯХ ГИПЕРТОНИИ ПРИ БОЛЕЗНИ 
ИЦЕНКО-CUSHINg И ПРИ ПЕРВИЧНОМ (ОПУХОЛЕВОМ) ГИПЕРКОРТИЦИЗМЕ
3. Бозаджиева 
Р Е З Ю М Е
Кровяное давление исследовалось у 319 больннх гиперкортицизмом, 
40 среди котормх с дизнцефальним синдромом, 225 — с тяжелой формой 
болезни Иценко-Cushing и 54 — с опухолевим гиперкортицизмом.
У 10% больнмх не било установлено наличия повьиненного артериаль- 
ного кровяного давления, у 46,7% била доброкачественная гипертония и 
у 43,3% — злокачественная. Существенного различия в распределений 
гипертонии между доброкачественной и злокачественной не удалось 
установить. Злокачественной гипертонией били поражени в одинаковой 
степени как мужчинн, так и женщини.
При сопоставлении кровяного давления с таковнм при гипертониче- 
ской болезни устанавливаются, в обшем, более низкие цифри, причем зта 
тенденция ярче всего виявлена при пульсовом давлении, которое при 
веех формах гиперкортицизма значительно ниже, чем таковое при гипер- 
тонической болезни, а во многих случаях не отличается от такового у 
здорових людей.
